Annual EBIT
-$116.31 M
-$31.16 M-36.59%
31 December 2023
Summary:
Aclaris Therapeutics annual earnings before interest & taxes is currently -$116.31 million, with the most recent change of -$31.16 million (-36.59%) on 31 December 2023. During the last 3 years, it has fallen by -$67.80 million (-139.73%). ACRS annual EBIT is now -2112.55% below its all-time high of -$5.25 million.ACRS EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$9.67 M
+$2.98 M+23.57%
30 September 2024
Summary:
Aclaris Therapeutics quarterly earnings before interest & taxes is currently -$9.67 million, with the most recent change of +$2.98 million (+23.57%) on 30 September 2024. Over the past year, it has increased by +$19.91 million (+67.31%). ACRS quarterly EBIT is now -272.53% below its all-time high of -$2.60 million, reached on 30 June 2015.ACRS Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$62.17 M
+$19.91 M+24.26%
30 September 2024
Summary:
Aclaris Therapeutics TTM earnings before interest & taxes is currently -$62.17 million, with the most recent change of +$19.91 million (+24.26%) on 30 September 2024. Over the past year, it has increased by +$52.40 million (+45.74%). ACRS TTM EBIT is now -2235.61% below its all-time high of -$2.66 million, reached on 30 September 2014.ACRS TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRS EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -36.6% | +67.3% | +45.7% |
| 3 y3 years | -139.7% | +50.1% | -6.7% |
| 5 y5 years | -37.2% | +57.7% | +38.2% |
ACRS EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -139.7% | at low | at high | +70.0% | -6.7% | +46.5% |
| 5 y | 5 years | -139.7% | at low | at high | +70.0% | -32.6% | +46.5% |
| alltime | all time | -2112.6% | at low | -272.5% | +70.0% | -2235.6% | +46.5% |
Aclaris Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$9.67 M(-23.6%) | -$62.17 M(-24.3%) |
| June 2024 | - | -$12.65 M(-21.6%) | -$82.09 M(-19.3%) |
| Mar 2024 | - | -$16.13 M(-32.0%) | -$101.73 M(-12.5%) |
| Dec 2023 | -$116.31 M(+36.6%) | -$23.72 M(-19.8%) | -$116.31 M(+1.5%) |
| Sept 2023 | - | -$29.58 M(-8.4%) | -$114.58 M(+10.5%) |
| June 2023 | - | -$32.29 M(+5.1%) | -$103.67 M(+8.2%) |
| Mar 2023 | - | -$30.72 M(+39.8%) | -$95.77 M(+12.5%) |
| Dec 2022 | -$85.15 M(+30.2%) | -$21.98 M(+17.7%) | -$85.15 M(+1.5%) |
| Sept 2022 | - | -$18.67 M(-23.4%) | -$83.87 M(-0.9%) |
| June 2022 | - | -$24.39 M(+21.3%) | -$84.59 M(+15.2%) |
| Mar 2022 | - | -$20.11 M(-2.8%) | -$73.40 M(+12.3%) |
| Dec 2021 | -$65.38 M(+34.8%) | -$20.69 M(+6.7%) | -$65.38 M(+12.2%) |
| Sept 2021 | - | -$19.39 M(+46.9%) | -$58.25 M(+19.6%) |
| June 2021 | - | -$13.21 M(+9.2%) | -$48.70 M(+3.9%) |
| Mar 2021 | - | -$12.09 M(-10.8%) | -$46.87 M(-3.4%) |
| Dec 2020 | -$48.52 M(-47.2%) | -$13.56 M(+37.8%) | -$48.52 M(-6.3%) |
| Sept 2020 | - | -$9.84 M(-13.5%) | -$51.78 M(-20.1%) |
| June 2020 | - | -$11.38 M(-17.2%) | -$64.80 M(-17.5%) |
| Mar 2020 | - | -$13.74 M(-18.3%) | -$78.52 M(-14.5%) |
| Dec 2019 | -$91.82 M | -$16.82 M(-26.4%) | -$91.83 M(-8.7%) |
| Sept 2019 | - | -$22.86 M(-8.9%) | -$100.56 M(+1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | -$25.10 M(-7.2%) | -$99.03 M(-5.2%) |
| Mar 2019 | - | -$27.05 M(+5.9%) | -$104.42 M(-3.6%) |
| Dec 2018 | -$84.78 M(+58.9%) | -$25.54 M(+19.7%) | -$108.31 M(+20.1%) |
| Sept 2018 | - | -$21.34 M(-30.0%) | -$90.15 M(+3.0%) |
| June 2018 | - | -$30.48 M(-1.5%) | -$87.56 M(+22.7%) |
| Mar 2018 | - | -$30.95 M(+319.3%) | -$71.38 M(+33.8%) |
| Dec 2017 | -$53.36 M(+10.6%) | -$7.38 M(-60.7%) | -$53.36 M(-6.9%) |
| Sept 2017 | - | -$18.76 M(+31.2%) | -$57.31 M(+16.1%) |
| June 2017 | - | -$14.29 M(+10.6%) | -$49.36 M(+2.7%) |
| Mar 2017 | - | -$12.93 M(+14.2%) | -$48.06 M(-0.4%) |
| Dec 2016 | -$48.27 M(+133.5%) | -$11.33 M(+4.8%) | -$48.27 M(+15.6%) |
| Sept 2016 | - | -$10.81 M(-16.8%) | -$41.74 M(+0.4%) |
| June 2016 | - | -$12.99 M(-1.1%) | -$41.57 M(+33.3%) |
| Mar 2016 | - | -$13.14 M(+173.6%) | -$31.18 M(+50.9%) |
| Dec 2015 | -$20.67 M(+142.2%) | -$4.80 M(-54.9%) | -$20.67 M(+11.9%) |
| Sept 2015 | - | -$10.64 M(+309.9%) | -$18.47 M(+76.1%) |
| June 2015 | - | -$2.60 M(-1.3%) | -$10.49 M(+32.9%) |
| Mar 2015 | - | -$2.63 M(+1.0%) | -$7.89 M(+49.9%) |
| Dec 2014 | -$8.53 M(+62.3%) | -$2.60 M(-2.3%) | -$5.26 M(+97.7%) |
| Sept 2014 | - | -$2.66 M | -$2.66 M |
| Dec 2013 | -$5.26 M | - | - |
FAQ
- What is Aclaris Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Aclaris Therapeutics?
- What is Aclaris Therapeutics annual EBIT year-on-year change?
- What is Aclaris Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Aclaris Therapeutics?
- What is Aclaris Therapeutics quarterly EBIT year-on-year change?
- What is Aclaris Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Aclaris Therapeutics?
- What is Aclaris Therapeutics TTM EBIT year-on-year change?
What is Aclaris Therapeutics annual earnings before interest & taxes?
The current annual EBIT of ACRS is -$116.31 M
What is the all time high annual EBIT for Aclaris Therapeutics?
Aclaris Therapeutics all-time high annual earnings before interest & taxes is -$5.25 M
What is Aclaris Therapeutics annual EBIT year-on-year change?
Over the past year, ACRS annual earnings before interest & taxes has changed by -$31.16 M (-36.59%)
What is Aclaris Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of ACRS is -$9.67 M
What is the all time high quarterly EBIT for Aclaris Therapeutics?
Aclaris Therapeutics all-time high quarterly earnings before interest & taxes is -$2.60 M
What is Aclaris Therapeutics quarterly EBIT year-on-year change?
Over the past year, ACRS quarterly earnings before interest & taxes has changed by +$19.91 M (+67.31%)
What is Aclaris Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of ACRS is -$62.17 M
What is the all time high TTM EBIT for Aclaris Therapeutics?
Aclaris Therapeutics all-time high TTM earnings before interest & taxes is -$2.66 M
What is Aclaris Therapeutics TTM EBIT year-on-year change?
Over the past year, ACRS TTM earnings before interest & taxes has changed by +$52.40 M (+45.74%)